다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Scientific reports, v.8, 2018년, pp.288 - 288
Silva, Valdenizia Rodrigues (Gonç) , Corrêa, Rodrigo S. (alo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ) , Santos, Luciano de Souza (Department of Chemistry, Federal University of Ouro Preto, Ouro Preto, Minas Gerais, 35400-000, Brazil) , Soares, Milena Botelho Pereira (Gonç) , Batista, Alzir Azevedo (alo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ) , Bezerra, Daniel Pereira (Gonç)
AI-Helper
Combination of multifunctionalities into one compound is a rational strategy in medicinal chemical design, and have often been used with metallodrug-based compounds. In the present study, we synthesized a novel ruthenium-based 5-fluorouracil complex [Ru(5-FU)(PPh3)2(bipy)]PF6 (PPh3 = t...
1. Ferlay J Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 International Journal of Cancer 2015 136 E359 E386 10.1002/ijc.29210 25220842
2. Vogel A Hofheinz RD Kubicka S Arnold D Treatment decisions in metastatic colorectal cancer - Beyond first and second line combination therapies Cancer Treatment Reviews 2017 59 54 60 10.1016/j.ctrv.2017.04.007 28738235
3. Giacchetti S Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracilleucovorin as first-line treatment of metastatic colorectal cancer Journal of Clinical Oncology 2000 18 136 147 10.1200/JCO.2000.18.1.136 10623704
4. Douillard JY Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Lancet 2000 355 1041 1047 10.1016/S0140-6736(00)02034-1 10744089
5. Johnston PG Kaye S Capecitabine: a novel agent for the treatment of solid tumors Anticancer Drugs 2001 12 639 646 10.1097/00001813-200109000-00001 11604550
6. Longley DB Harkin DP Johnston PG 5-fluorouracil: mechanisms of action and clinical strategies Nature Reviews Cancer 2003 3 330 338 10.1038/nrc1074 12724731
7. Tjandra JJ Chan MK Follow-up after curative resection of colorectal cancer: a meta-analysis Diseases of the Colon & Rectum 2007 50 1783 1799 10.1007/s10350-007-9030-5 17874269
8. Lentz F Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study Anticancer Drugs 2009 20 97 103 10.1097/CAD.0b013e328322fbc5 19209025
9. Leijen S Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy Investigational New Drugs 2015 33 201 214 10.1007/s10637-014-0179-1 25344453
10. Zeng L Ruthenium(II) complexes with 2-phenylimidazo[4,5-f][1,10]phenanthroline derivatives that strongly combat cisplatin-resistant tumor cells Scientific Reports 2016 6 19449 10.1038/srep19449 26763798
11. Wan D Ruthenium (II) polypyridyl complexes: synthesis, characterization and anticancer activity studies on BEL-7402 cells Journal of Inorganic Biochemistry 2017 173 1 11 10.1016/j.jinorgbio.2017.04.026 28472754
12. Costa, C. O. D. et al . Novel piplartine-containing ruthenium complexes: synthesis, cell growth inhibition, apoptosis induction and ROS production on HCT116 cells. Oncotarget , 8 , 104367–104392 (2017).
13. Liu KG Cai XQ Li XC Qin DA Hu ML Arene-ruthenium(II) complexes containing 5-fluorouracil-1-methyl isonicotinate: Synthesis and characterization of their anticancer activity Inorganica Chimica Acta 2012 388 78 83 10.1016/j.ica.2012.02.046
14. Li ZJ Hou Y Qin DA Jin ZM Hu ML Two half-sandwiched ruthenium (II) compounds containing 5-fluorouracil derivatives: synthesis and study of DNA intercalation Plos One 2015 10 e0120211 10.1371/journal.pone.0120211 25789618
15. Correa RS Ruthenium(II) complexes of 1,3-thiazolidine-2-thione: Cytotoxicity against tumor cells and anti- Trypanosoma cruzi activity enhanced upon combination with benznidazole Journal of Inorganic Biochemistry 2016 156 153 163 10.1016/j.jinorgbio.2015.12.024 26795676
16. Fallon L III. The crystal and molecular structure of 5-fluorouracil Acta Crystallographica 1973 B29 2549 2556 10.1107/S0567740873006989
17. Santos ER New ruthenium(II)/phosphines/diimines complexes: Promising antitumor (human breast cancer) and Mycobacterium tuberculosis fighting agents Polyhedron 2013 51 292 297 10.1016/j.poly.2013.01.004
18. Santos ER Ru(II)/bisphosphine/diimine/amino acid complexes: diastereoisomerism, cytotoxicity, and inhibition of tumor cell adhesion to collagen type I Journal of Coordination Chemistry 2016 69 3518 3530 10.1080/00958972.2016.1244334
19. Guo X Cell cycle perturbation and acquired 5-fluorouracil chemoresistance Anticancer Research 2008 28 9 14 18383818
20. Ijichi K Adachi M Ogawa T Hasegawa Y Murakami S Cell-cycle distribution and thymidilate synthatase (TS) expression correlate with 5-FU resistance in head and neck carcinoma cells Anticancer Research 2014 34 2907 2911 24922653
21. Chen LM The studies on the cytotoxicity in vitro , cellular uptake, cell cycle arrest and apoptosis-inducing properties of ruthenium methylimidazole complex [Ru(MeIm) 4 (p-cpip)] 2+ Journal of Inorganic Biochemistry 2016 156 64 74 10.1016/j.jinorgbio.2015.12.016 26775277
22. Nikolić S Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands Journal of Inorganic Biochemistry 2016 160 156 65 10.1016/j.jinorgbio.2016.01.005 26818702
23. Lamberti M Levofolene modulates apoptosis induced by 5-fluorouracil through autophagy inhibition: clinical and occupational implications International Journal of Oncology 2015 46 1893 900 10.3892/ijo.2015.2904 25709090
24. Feng Y Gao S Gao Y Wang X Chen Z Anti-EGFR antibody sensitizes colorectal cancer stem-like cells to Fluorouracil-induced apoptosis by affecting autophagy Oncotarget 2016 7 81402 81409 27833077
25. Čanović P Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity Journal of Biological Inorganic Chemistry 2017 22 1007 1028 10.1007/s00775-017-1479-7 28695374
26. Sheldrick G Crystal structure refinement with SHELXL Acta Crystallographica 2015 71 3 8
27. Macrae CF Mercury: visualization and analysis of crystal structures Journal of Applied Crystallography 2006 39 453 457 10.1107/S002188980600731X
28. Ahmed SA Gogal RM Walsh JE A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes an alternative to [ 3 H] thymidine incorporation assay Journal of Immunological Methods 1994 170 211 224 10.1016/0022-1759(94)90396-4 8157999
29. Nicoletti I Migliorati G Pagliacci MC Grignani F Riccardi C A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry Journal of Immunological Methods 1991 139 271 279 10.1016/0022-1759(91)90198-O 1710634
30. Sureda FX Mitochondrial membrane potential measurement in rat cerebellar neurons by flow cytometry Cytometry 1997 28 74 80 10.1002/(SICI)1097-0320(19970501)28:1 3.0.CO;2-H 9136758
31. Lebel CP Ischiropoulos H Bondy SC Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress Chemical Research in Toxicology 1992 5 227 231 10.1021/tx00026a012 1322737
32. Glass LS Bapat A Kelley MR Georgiadis MM Long EC Semi-automated high-throughput fluorescent intercalator displacement-based discovery of cytotoxic DNA binding agents from a large compound library Bioorganic & Medicinal Chemistry Letters 2010 20 1685 1688 10.1016/j.bmcl.2010.01.033 20144868
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.